{"id":47643,"date":"2025-11-13T20:58:59","date_gmt":"2025-11-13T12:58:59","guid":{"rendered":"https:\/\/flcube.com\/?p=47643"},"modified":"2025-11-13T20:59:00","modified_gmt":"2025-11-13T12:59:00","slug":"adicon-holdings-crown-bioscience-and-global-lab-services-forge-new-integrated-platform-for-oncology-translational-research","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=47643","title":{"rendered":"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research"},"content":{"rendered":"\n<p><strong>Adicon Holdings Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/9860:HKG\">HKG: 9860<\/a>), a leading independent clinic laboratory (ICL) service provider in China, today announced the execution of a definitive Share Purchase Agreement with <strong>JSR Life Sciences, LLC<\/strong> to acquire all issued shares of <strong>Crown Bioscience International<\/strong> (\u201cCrownBio\u201d). The transaction is valued at <strong>USD\u202f204\u202fmillion<\/strong> (including an earn\u2011out component) and is expected to close in mid\u20112026, pending customary post\u2011closing adjustments.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-transaction-overview\">Transaction Overview<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Buyer<\/strong><\/td><td>Adicon Holdings Ltd.<\/td><\/tr><tr><td><strong>Target<\/strong><\/td><td>Crown Bioscience International<\/td><\/tr><tr><td><strong>Consideration<\/strong><\/td><td>USD\u202f204\u202fmillion (base + earn\u2011out)<\/td><\/tr><tr><td><strong>Closing Window<\/strong><\/td><td>Mid\u20112026 (subject to regulatory &amp; customary adjustments)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Transformation<\/strong> \u2013 The acquisition upgrades Adicon from a domestic diagnostic platform into a <strong>global, integrated laboratory\u2011services provider<\/strong> spanning diagnostic testing, clinical development, and preclinical research.<\/li>\n\n\n\n<li><strong>Complementary Capabilities<\/strong> \u2013 Adicon\u2019s extensive nationwide ICL network will be merged with CrownBio\u2019s preclinical and translational oncology expertise, creating a unified pipeline that maximizes biomarker discovery and predictive translational tools.<\/li>\n\n\n\n<li><strong>Geographic Diversification<\/strong> \u2013 Post\u2011acquisition, roughly <strong>23.1\u202f%<\/strong> of the combined revenue is projected to come from outside China, expanding the company\u2019s international footprint.<\/li>\n\n\n\n<li><strong>Accelerated Innovation<\/strong> \u2013 The combined entity is positioned to accelerate drug development timelines and enhance the value proposition for oncology and immuno\u2011oncology sponsors.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>The statements in this release that are not based on historical facts are forward\u2011looking statements. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Adicon Holdings Ltd. (HKG: 9860), a leading independent clinic laboratory (ICL) service provider in China,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":47645,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[1150,19,3573,1149,3621],"class_list":["post-47643","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-adicon","tag-cro-cmo-cdmo","tag-crown-bioscience","tag-hkg-9860","tag-jsr-life-sciences"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Adicon Holdings Ltd. (HKG: 9860), a leading independent clinic laboratory (ICL) service provider in China, today announced the execution of a definitive Share Purchase Agreement with JSR Life Sciences, LLC to acquire all issued shares of Crown Bioscience International (\u201cCrownBio\u201d). The transaction is valued at USD\u202f204\u202fmillion (including an earn\u2011out component) and is expected to close in mid\u20112026, pending customary post\u2011closing adjustments.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=47643\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research\" \/>\n<meta property=\"og:description\" content=\"Adicon Holdings Ltd. (HKG: 9860), a leading independent clinic laboratory (ICL) service provider in China, today announced the execution of a definitive Share Purchase Agreement with JSR Life Sciences, LLC to acquire all issued shares of Crown Bioscience International (\u201cCrownBio\u201d). The transaction is valued at USD\u202f204\u202fmillion (including an earn\u2011out component) and is expected to close in mid\u20112026, pending customary post\u2011closing adjustments.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=47643\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-13T12:58:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-13T12:59:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47643#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47643\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research\",\"datePublished\":\"2025-11-13T12:58:59+00:00\",\"dateModified\":\"2025-11-13T12:59:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47643\"},\"wordCount\":238,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47643#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1301-1.webp\",\"keywords\":[\"Adicon\",\"CRO \\\/ CMO \\\/ CDMO\",\"Crown Bioscience\",\"HKG: 9860\",\"JSR Life Sciences\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=47643#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47643\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=47643\",\"name\":\"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47643#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47643#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1301-1.webp\",\"datePublished\":\"2025-11-13T12:58:59+00:00\",\"dateModified\":\"2025-11-13T12:59:00+00:00\",\"description\":\"Adicon Holdings Ltd. (HKG: 9860), a leading independent clinic laboratory (ICL) service provider in China, today announced the execution of a definitive Share Purchase Agreement with JSR Life Sciences, LLC to acquire all issued shares of Crown Bioscience International (\u201cCrownBio\u201d). The transaction is valued at USD\u202f204\u202fmillion (including an earn\u2011out component) and is expected to close in mid\u20112026, pending customary post\u2011closing adjustments.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47643#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=47643\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47643#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1301-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1301-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=47643#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research - Insight, China&#039;s Pharmaceutical Industry","description":"Adicon Holdings Ltd. (HKG: 9860), a leading independent clinic laboratory (ICL) service provider in China, today announced the execution of a definitive Share Purchase Agreement with JSR Life Sciences, LLC to acquire all issued shares of Crown Bioscience International (\u201cCrownBio\u201d). The transaction is valued at USD\u202f204\u202fmillion (including an earn\u2011out component) and is expected to close in mid\u20112026, pending customary post\u2011closing adjustments.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=47643","og_locale":"en_US","og_type":"article","og_title":"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research","og_description":"Adicon Holdings Ltd. (HKG: 9860), a leading independent clinic laboratory (ICL) service provider in China, today announced the execution of a definitive Share Purchase Agreement with JSR Life Sciences, LLC to acquire all issued shares of Crown Bioscience International (\u201cCrownBio\u201d). The transaction is valued at USD\u202f204\u202fmillion (including an earn\u2011out component) and is expected to close in mid\u20112026, pending customary post\u2011closing adjustments.","og_url":"https:\/\/flcube.com\/?p=47643","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-13T12:58:59+00:00","article_modified_time":"2025-11-13T12:59:00+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=47643#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=47643"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research","datePublished":"2025-11-13T12:58:59+00:00","dateModified":"2025-11-13T12:59:00+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=47643"},"wordCount":238,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=47643#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301-1.webp","keywords":["Adicon","CRO \/ CMO \/ CDMO","Crown Bioscience","HKG: 9860","JSR Life Sciences"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=47643#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=47643","url":"https:\/\/flcube.com\/?p=47643","name":"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=47643#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=47643#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301-1.webp","datePublished":"2025-11-13T12:58:59+00:00","dateModified":"2025-11-13T12:59:00+00:00","description":"Adicon Holdings Ltd. (HKG: 9860), a leading independent clinic laboratory (ICL) service provider in China, today announced the execution of a definitive Share Purchase Agreement with JSR Life Sciences, LLC to acquire all issued shares of Crown Bioscience International (\u201cCrownBio\u201d). The transaction is valued at USD\u202f204\u202fmillion (including an earn\u2011out component) and is expected to close in mid\u20112026, pending customary post\u2011closing adjustments.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=47643#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=47643"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=47643#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301-1.webp","width":1080,"height":608,"caption":"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=47643#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Adicon Holdings, Crown Bioscience, and Global Lab Services Forge New Integrated Platform for Oncology Translational Research"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1301-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/47643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=47643"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/47643\/revisions"}],"predecessor-version":[{"id":47646,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/47643\/revisions\/47646"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/47645"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=47643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=47643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=47643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}